연구성과로 돌아가기
2025 연구성과별 연구자 정보 (326 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke | San An, Chun | San An, C | 32 | GNT Pharm Co Ltd, Yongin, South Korea | jinsoo22@gmail.com; | |||||
| Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke | Gwag, Byoung Joo | Gwag, BJ | 33 | GNT Pharm Co Ltd, Yongin, South Korea | jinsoo22@gmail.com; | |||||
| Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke | Choi, Dennis W. | Choi, DW | 34 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea | jinsoo22@gmail.com; | |||||
| Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke | Choi, Dennis W. | Choi, DW | 34 | Stony Brook Univ, Sch Med, Dept Neurol, Stony Brook, NY, USA | jinsoo22@gmail.com; | |||||
| Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke | Hong, Ji Man | Hong, JM | 35 | Ajou Univ, Med Ctr, Sch Med, Dept Neurol, 164 Worldcup Ro, Suwon 16499, South Korea | AAE-2686-2022 | Hong, Ji Man | jinsoo22@gmail.com; | |||
| Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke | Kwon, Sun U. | Kwon, SU | 36 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea | jinsoo22@gmail.com; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Lim, Young-Suk | Lim, YS | 1 | 교신저자 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol,Asan Liver Ctr, Seoul, South Korea | AFQ-5165-2022 | Lim, Young-Suk | limys@amc.seoul.kr; | ||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Yu, Ming-Lung | Yu, ML | 2 | Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan | AAZ-4306-2020 | Yu, Ming-Lung | 0000-0001-8145-1900 | Yu, Ming-Lung | limys@amc.seoul.kr; | |
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Choi, Jonggi | Choi, J | 3 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol,Asan Liver Ctr, Seoul, South Korea | L-1521-2019 | Choi, Jonggi | limys@amc.seoul.kr; | |||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Chen, Chi-Yi | Chen, CY | 4 | Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Choi, Won-Mook | Choi, WM | 5 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol,Asan Liver Ctr, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Kang, Wonseok | Kang, W | 6 | Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Kim, Gi-Ae | Kim, GA | 7 | Kyung Hee Univ, Kyung Hee Univ Hosp, Seoul, South Korea | AAZ-2547-2021 | Kim, Gi-Ae | limys@amc.seoul.kr; | |||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Kim, Hyung Joon | Kim, HJ | 8 | Chung Ang Univ, Chung Ang Univ Hosp, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Bin Lee, Yun | Bin Lee, Y | 9 | Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea | limys@amc.seoul.kr; |
페이지 이동: